SOLUBLE PROGRAMMED CELL DEATH-1 IN PSORIASIS AND PSORIATIC ARTHRITIS PATIENTS

被引：0
|
作者：
Tabra, S. A. A. [1 ]
Elsharaby, R. [2 ]
Shaker, E. S. E. [3 ]
Moustafa, A. A. [4 ]
Abu-Zaid, M. H. [1 ]
机构：
[1] Tanta Univ, Rheumatol & Rehabil, Fac Med, Tanta, Egypt
[2] Tanta Univ, Clin Pathol, Fac Med, Tanta, Egypt
[3] Tanta Univ, Dermatol & Venereol, Fac Med, Tanta, Egypt
[4] Al Azhar Univ, Rheumatol & Rehabil, New Damietta Branch, Dumyat, Egypt
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis;
D O I：
10.1136/annrheumdis-2023-eular.399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1155
引用
收藏
页码：1807 / 1807
页数：1
相关论文
共 50 条
  • [41] Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold
    Qin, Mingze
    Cao, Qi
    Wu, Xia
    Liu, Chunyang
    Zheng, Shuaishuai
    Xie, Hongbo
    Tian, Ye
    Xie, Jun
    Zhao, Yanfang
    Hou, Yunlei
    Zhang, Xian
    Xu, Boxuan
    Zhang, Haotian
    Wang, Xiaobo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [42] Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis
    Chandran, Vinod
    Cook, Richard J.
    Edwin, Jonathan
    Shen, Hua
    Pellett, Fawnda J.
    Shanmugarajah, Sutharshini
    Rosen, Cheryl F.
    Gladman, Dafna D.
    RHEUMATOLOGY, 2010, 49 (07) : 1399 - 1405
  • [43] Role of soluble programmed death-1 (sPD-1) and sPD- ligand 1 in patients with cystic echinococcosis
    Li, Yanhua
    Xiao, Yunfeng
    Su, Mingquan
    Zhang, Rong
    Ding, Jianbing
    Hao, Xiaoke
    Ma, Yueyun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (01) : 251 - 256
  • [44] Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies
    Robert, Caroline
    Soria, Jean-Charles
    Eggermont, Alexander M. M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 2968 - 2971
  • [45] Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis
    Cai, Li
    Zhang, Chenxing
    Wu, Jing
    Zhou, Wei
    Chen, Tongxin
    CLINICAL IMMUNOLOGY, 2021, 229
  • [46] Programmed Cell Death-1 and Its Ligands as Targets for Therapy of Multiple Myeloma Patients
    Karczmarczyk, Agnieszka
    Korpysz, Maciej
    Bilska, Sylwia
    Purkot, Joanna
    Hus, Marek
    Giannopoulos, Krzysztof
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1267 - 1281
  • [47] Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
    Goto, Hiroyuki
    Sugita, Kazunari
    Yamamoto, Osamu
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (02) : 169 - 173
  • [48] Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
    Kim, Ji-Hyun
    Kim, Shinn-Young
    Shin, Eun-Young
    Jung, Ji-Han
    Choi, Hyun-Joo
    Jun, Kyong-Hwa
    ONCOLOGY LETTERS, 2019, 18 (03) : 2661 - 2669
  • [49] Verification of Novel Soluble Biomarkers That Differentiate Patients with Psoriatic Arthritis from Those with Psoriasis without Psoriatic Arthritis
    Chandran, Vinod
    Cretu, Daniela
    Gao, Lisa
    Liang, Kun
    Soosaipillai, Antoninus
    Diamandis, Eleftherios
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils
    Zhao, Cathy Yunjia
    Consuegra, Germana
    Chou, Shaun
    Fernandez-Penas, Pablo
    MELANOMA RESEARCH, 2017, 27 (06) : 641 - 644
12345